Kelix bio, an emerging markets biopharmaceuticals platform, including its four subsidiaries, is to be acquired by Mubadala Investment Company, the Abu Dhabi investor with over US$276bn in assets under management….
UAE: Investors to sell Kelix bio to Mubadala
…
…






